Wealth Effects LLC Buys Shares of 14,490 Astera Labs, Inc. $ALAB

Wealth Effects LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 14,490 shares of the company’s stock, valued at approximately $6,999,000. Astera Labs makes up about 1.9% of Wealth Effects LLC’s investment portfolio, making the stock its 11th largest position.

A number of other institutional investors and hedge funds have also made changes to their positions in ALAB. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC lifted its stake in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in Astera Labs during the fourth quarter worth about $33,000. Whipplewood Advisors LLC boosted its holdings in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares in the last quarter. Finally, Assetmark Inc. grew its position in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after buying an additional 101 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have issued reports on ALAB shares. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Stifel Nicolaus boosted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Needham & Company LLC upped their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Susquehanna raised their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $325.25.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the sale, the director owned 53,961 shares in the company, valued at approximately $16,826,658.63. This represents a 6.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director directly owned 286,863 shares of the company’s stock, valued at $131,492,261.94. The trade was a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 940,716 shares of company stock worth $292,425,777 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $321.61 on Monday. The company has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. The firm has a 50-day moving average price of $358.00 and a two-hundred day moving average price of $240.74. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.